Science news brief
New Zealand drugs regulator approves use of MDMA to treat severe PTSD
NEWS DESKScience
PUBLISHEDSep 4, 2026, 4:27 AM
What the source reports
New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD).
The move by New Zealand’s pharmaceutical regulatory body Medsafe makes the country only the second worldwide to approve the party drug for…
Main source: The Guardian Science
TDBN presents the written preview supplied through the publisher's feed. Complete reporting, continuing updates, context, and corrections remain with the original report.
Read the complete report ↗